Nils Paust,
Head of Division Microfluidic Platforms,
Hahn-Schickard-Gesellschaft für Angewandte Forschung eV
PD Dr Nils Paust has a background in energy and process engineering. He received his PhD on the topic of micro fuel cells at the University of Freiburg in 2010. In February 2010, he joined the lab-on-chip research activities at Hahn-Schickard in Freiburg, first as a group leader, then as head of division microfluidic platforms and nowadays as an executive board member of Hahn-Schickard. In 2020, he completed his habilitation and co-founded the Dermagnostix GmbH in 2021. Main research interest of Nils Paust is the centrifugal microfluidic system integration. This comprises new microfluidic functionalities, cost-efficient mass fabrication of microfluidic chips and the implementation of complete laboratory workflows on centrifugal microfluidic platforms.
Microfluidic Platforms for Diagnostics – From Idea to Production
Tuesday, 20 June 2023 at 16:30
Add to Calendar ▼2023-06-20 16:30:002023-06-20 17:30:00Europe/LondonMicrofluidic Platforms for Diagnostics – From Idea to ProductionPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Several decades of microfluidic research and development are now behind us and I would like to share some strategies of commercialization that are used at Hahn-Schickard. We attempt to cover the complete value chain from idea to production. Microfluidic design, research labs equipped with biosafety, and rapid prototyping facilities are required for the first proof of concepts. However, in total, four manufacturing lines are needed to accompany the development from idea to production. In a next step, we need to improve the level of confidence by scaling up production and test in clinical environments. For market entry, a certified production line should provide thousands of cartridges and eventually, fully automated high throughput manufacturing should provide cartridges for low prices. Simultaneously, a processing device must be developed, first as a measurement set-up, then as a functional model, and eventually as a product. In this talk, on the example of centrifugal microfluidic platforms, I will discuss applications and share our experiences on the different levels of microfluidic development.
Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2023-06-20 16:30:002023-06-20 17:30:00Europe/LondonMicrofluidic Platforms for Diagnostics – From Idea to ProductionPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
